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Abstract
Background: Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) is a rare, but well-defined syndrome com-
prising polyarthritis with symmetrical synovitis of the small joints in hands and feet accompanied by marked pitting edema. It
is often considered a paraneoplastic syndrome, but here we report a case with F-18-fluorodeoxyglucose positron emission tomog-
raphy/computed tomography (FDG-PET/CT) findings of polymyalgia rheumatica (PMR) in a patient with RS3PE and suspected of
paraneoplastic syndrome.
Objectives: To briefly report the potential of FDG-PET/CT in rheumatic settings.
Methods: An 83-year-old male with a history of prostate adenocarcinoma simultaneously with RS3PE presented with pain and stiff-
ness of the shoulder and hip girdles to the department of rheumatology. He was anemic and had hypersedimentation of 106. He
also complained of sore and swollen hands compatible with RS3PE. The patient had a previous course of RS3PE, presented as a para-
neoplastic syndrome, together with his prostate cancer one year earlier, which resolved when the prostatic cancer was in remission.
FDG-PET/CT was performed due to suspicion of repeat paraneoplastic syndrome.
Results: FDG-PET/CT findings showed no evidence of malignant disease. There was diffusely increased FDG in soft tissue around the
shoulders and hips and FDG-positive axillary lymph nodes consistent with PMR.
Conclusions: RS3PE and PMR may belong to the same clinical entity. FDG-PET/CT has a potential role in the management of PMR as
well as other rheumatic diseases.
Keywords: FDG-PET/CT, Polymyalgia Rheumatica, RS3PE, Paraneoplastic Syndrome, Rheumatology
1. Background
Remitting seronegative symmetrical synovitis with
pitting edema (RS3PE), first described by McCarthy et al. 30
years ago, is a rare, but well-defined syndrome comprising
polyarthritis with symmetrical synovitis of the small joints
in hands and feet accompanied by marked pitting edema
following sudden-onset inflammation (1, 2). Though the
etiology of RS3PE is still unknown, infections and environ-
mental factors have been reported to be correlated with
the disease (3). It is often considered a paraneoplastic syn-
drome which presents frequently together with prostate,
stomach and colon cancer, however in recent decades sev-
eral benign etiologies have been reported, and today a
common differential diagnosis is polymyalgia Rheumatica
(PMR) (2, 4). Diagnosis of RS3PE is based on clinical findings
and low dose steroids are the mainstay of treatment. RS3PE
responds well to treatment and remains in remission for
a long time unless induced by other etiology e.g. malig-
nancy.
PMR occurs commonly in elderly (> 50 years) and is
characterized by inflammatory pain and stiffness of the
shoulder and pelvic griddles together with elevation of
inflammatory markers. PMR is a clinical diagnosis based
on the complex of presenting symptoms and exclusion
of the other potential diseases; however this poses many
challenges due to a wide range of differential diagnosis.
Furthermore, there is no diagnostic test which is specific
for PMR. Corticosteroids are considered the treatment of
choice (5).
It has suggested that PMR and RS3PE are different man-
ifestations of the same clinical entity, or at least induced by
the same mechanisms despite underlying etiology (6). The
present report also points in this direction with the pres-
ence of PMR and RS3PE as well as prostatic cancer and RS3PE
at the same time. F-18-fluorodeoxyglucose positron emis-
sion tomography/computed tomography’s (FDG-PET/CT)
impact on oncologic imaging needs no introduction, but
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for suspected paraneoplastic syndromes it is only emerg-
ing as a potentially superior modality (7, 8). The same
can be said for the use of FDG-PET/CT in inflammatory dis-
eases, including rheumatologic settings, where the most
frequent clinical use is in fever of unknown origin and vas-
culitis, but with an increasing awareness of other entities
as well, e.g. rheumatic arthritis (9, 10).
2. Objectives
Employment of FDG-PET/CT for RS3PE has been re-
ported rarely in patients with suspected malignant dis-
eases (11). The objective of present report is to illustrate
the diagnostic potential of FDG-PET/CT in rheumatic syn-
dromes, not only when malignancies are suspected, but
also when inflammatory diseases may be the inducer.
3. Methods
An 83-year-old male with a history of prostate adeno-
carcinoma simultaneously with RS3PE was referred to the
Department of Rheumatology with pain and stiffness of
the shoulder and hip girdles. He was anemic (Hemoglobin:
5.7 mmol/L, normal range: 8 - 11 mmol/L) with increased
erythrocyte sedimentation rate (ESR: 106, normal range <
20). He also complained of sore and swollen hands com-
patible with RS3PE. Further history taking revealed a previ-
ous course of RS3PE together with his prostate cancer one
year earlier. This presented as a paraneoplastic syndrome
and resolved when the prostatic cancer was in remission.
FDG-PET/CT imaging was performed on obvious suspicion
of repeat paraneoplastic syndrome, either progression of
prostate cancer or a novel, secondary cancer with accom-
panying RS3PE. Contrary to expectations, FDG-PET/CT find-
ings were benign with no evidence of recurrence or bone
metastasis. Instead temporal artery biopsy was performed,
to diagnose a possible inflammation, which was negative.
Thus, clinical findings and imaging were consistent with
PMR with accompanying RS3PE and prednisolone 15 mg
daily was initiated. This resulted in rapid and complete res-
olution of the symptoms. Prednisolone was ceased after
18 months of treatment initiation without any adverse ef-
fects.
4. Results
(Figure 1A) Maximum intensity projection whole-body
FDG-PET/CT, and (Figure 1B) fused axial FDG-PET/CT scans
of the shoulders and hips in a patient suspected of ma-
lignant disease due to RS3PE. There is diffusely increased
FDG (circles) in soft tissue around the shoulders and hips
and FDG-positive axillary lymph nodes (arrows) consistent
with PMR. To the best of our knowledge, this is the first case
in the literature in which FDG-PET/CT delineated the under-
lying ethology of RS3PE in a benign, rheumatic setting.
Figure 1. 1A-1B: FDG-PET/CT Findings in a PMR Patient Initially Suspected to Have Ma-
lignant Disease
5. Discussion
In conclusion, this report presented a case of RS3PE to-
gether with prostate cancer and PMR, though not at the
same time, provoking thought that they belong to the
same clinical entity as also suggested by previous stud-
ies (12). Additionally, this report elucidates the diagnos-
tic potential of FDG-PET/CT in PMR and possibly in other
rheumatic diseases.
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